These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28013248)

  • 1. Kynurenine Pathway Activation in Human African Trypanosomiasis.
    Sternberg JM; Forrest CM; Dalton RN; Turner C; Rodgers J; Stone TW; Kennedy PGE
    J Infect Dis; 2017 Mar; 215(5):806-812. PubMed ID: 28013248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.
    MacLean L; Reiber H; Kennedy PG; Sternberg JM
    PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients.
    Maclean L; Odiit M; Sternberg JM
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):270-5. PubMed ID: 16343570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
    Rodgers J; Stone TW; Barrett MP; Bradley B; Kennedy PG
    Brain; 2009 May; 132(Pt 5):1259-67. PubMed ID: 19339256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense Infection.
    Lamour SD; Alibu VP; Holmes E; Sternberg JM
    J Infect Dis; 2017 Dec; 216(10):1273-1280. PubMed ID: 28927234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
    Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
    J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.
    Kato CD; Alibu VP; Nanteza A; Mugasa CM; Matovu E
    PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003835. PubMed ID: 26090964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
    MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM
    PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway.
    Luo Y; Möhn N; Skripuletz T; Senel M; Tumani H; Peßler F; Sühs KW; Stangel M
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2228-2234. PubMed ID: 34623755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of endotoxaemia to peripheral and central nervous system inflammatory responses in Human African Trypanosomiasis.
    Maclean L; Aboubaker EA; Kennedy PG; Sternberg JM
    Parasitology; 2017 Apr; 144(4):557-562. PubMed ID: 27894360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Nyawira Maranga D; Kagira JM; Kinyanjui CK; Muturi Karanja S; Wangari Maina N; Ngotho M
    Clin Dev Immunol; 2013; 2013():320509. PubMed ID: 24194772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease.
    Iwaoka K; Otsuka C; Maeda T; Yamahara K; Kato K; Takahashi K; Takahashi K; Terayama Y
    Neurosci Lett; 2020 Jan; 714():134576. PubMed ID: 31654722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
    Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
    Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
    Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites.
    Yan J; Han VX; Heng B; Guillemin GJ; Bandodkar S; Dale RC
    EBioMedicine; 2022 Mar; 77():103917. PubMed ID: 35279631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
    Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections.
    Sühs KW; Novoselova N; Kuhn M; Seegers L; Kaever V; Müller-Vahl K; Trebst C; Skripuletz T; Stangel M; Pessler F
    J Infect Dis; 2019 Jun; 220(1):127-138. PubMed ID: 30721966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections.
    Quist-Paulsen E; Aukrust P; Kran AB; Dunlop O; Ormaasen V; Stiksrud B; Midttun Ø; Ueland T; Ueland PM; Mollnes TE; Dyrhol-Riise AM
    J Neuroinflammation; 2018 Nov; 15(1):327. PubMed ID: 30470234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys.
    Ngotho M; Kagira JM; Jensen HE; Karanja SM; Farah IO; Hau J
    Trop Med Int Health; 2009 Jul; 14(7):736-47. PubMed ID: 19573160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.